antisense | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

684 results for “antisense”

Trials

View all 228 →

Antisense Oligonucleotide for Spinal Muscular Atrophy

1,000 participants · First posted Jan 11, 2022

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

59 participants · First posted Sep 4, 2020

Quantification of Antisense HIV RNA in Patients

60 participants · First posted May 19, 2022

Drugs

View all 177 →

ICN-16064

antisense oligonucleotide

Antisense oligonucleotides

Organizations

Antisense Therapeutics Ltd

PERCHERON THERAPEUTICS LIMITED

Australia

Ionis Pharmaceuticals, Inc.

United States

News

View all 273 →

Antisense Oligonucleotide Therapies Advance in Genetic Medicine

Antisense Oligonucleotides: Rewriting the Future of Rare Inherited Genetic Diseases

Vanda Pharmaceuticals' VGT-1849A, a Selective JAK2 Inhibitor, Receives FDA Orphan Drug Designation for Polycythemia Vera

Page 1 of 69